Authors
Loading...
This review highlights deoxynojirimycin's role in glucose regulation in type 2 diabetes, suggesting additional health benefits in obesity and lipid metabolism.
Tejaswini et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: